InnovAge Holding Corp. (INNV) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
22/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinINNV / S&P 47.76% / 15.20% |
LoseINNV / S&P INNV unavailable / 15.00% |
LoseINNV / S&P INNV unavailable / 50.40% |
| 2026-Q12/3 |
WinINNV / S&P 54.53% / -4.33% |
WinINNV / S&P 14.13% / 11.30% |
LoseINNV / S&P -66.67% / 27.70% |
| 2025-Q41/3 |
LoseINNV / S&P 0.58% / 2.65% |
WinINNV / S&P 13.48% / 9.00% |
LoseINNV / S&P -130.00% / 13.40% |
| 2025-Q32/3 |
WinINNV / S&P 39.84% / 8.12% |
WinINNV / S&P 12.48% / 4.61% |
LoseINNV / S&P -7.69% / 13.45% |
| 2025-Q23/3 |
WinINNV / S&P 23.83% / 10.94% |
WinINNV / S&P 11.76% / 4.83% |
WinINNV / S&P 29.41% / 10.63% |
| 2025-Q11/3 |
LoseINNV / S&P -24.17% / -4.27% |
WinINNV / S&P 12.19% / 4.98% |
LoseINNV / S&P 4.35% / 10.57% |
| 2024-Q41/3 |
LoseINNV / S&P -34.50% / 2.41% |
WinINNV / S&P 11.91% / 5.25% |
LoseINNV / S&P -16.67% / 6.15% |
| 2024-Q32/3 |
WinINNV / S&P 20.97% / 5.89% |
WinINNV / S&P 12.46% / 5.89% |
LoseINNV / S&P -53.57% / 6.11% |
| 2024-Q22/3 |
WinINNV / S&P 11.71% / 4.28% |
WinINNV / S&P 11.01% / 5.38% |
LoseINNV / S&P -43.33% / 5.12% |
| 2024-Q11/3 |
LoseINNV / S&P -26.00% / 10.56% |
WinINNV / S&P 8.37% / 5.71% |
LoseINNV / S&P -28.13% / 5.59% |
| 2023-Q40/3 |
LoseINNV / S&P 0.17% / 11.69% |
LoseINNV / S&P 4.63% / 6.81% |
LoseINNV / S&P -17.24% / 7.78% |
| 2023-Q31/3 |
LoseINNV / S&P -20.13% / -3.27% |
LoseINNV / S&P 0.37% / 7.52% |
WinINNV / S&P 33.33% / -5.03% |
| 2023-Q21/3 |
LoseINNV / S&P -6.02% / 8.74% |
LoseINNV / S&P -1.51% / 9.50% |
WinINNV / S&P 500.00% / -8.57% |
| 2023-Q11/3 |
WinINNV / S&P 11.14% / 7.50% |
LoseINNV / S&P -1.91% / 10.77% |
LoseINNV / S&P -390.91% / -15.69% |
| 2022-Q41/3 |
WinINNV / S&P 22.11% / 7.56% |
LoseINNV / S&P 1.86% / 11.88% |
LoseINNV / S&P -825.00% / -17.99% |
| 2022-Q31/3 |
WinINNV / S&P 34.25% / -4.88% |
LoseINNV / S&P 5.85% / 13.47% |
LoseINNV / S&P -290.91% / -1.41% |
| 2022-Q20/3 |
LoseINNV / S&P -31.78% / -16.10% |
LoseINNV / S&P 9.54% / 13.71% |
LoseINNV / S&P -86.11% / 11.04% |
| 2022-Q11/3 |
WinINNV / S&P 28.40% / -4.60% |
LoseINNV / S&P 12.72% / 15.97% |
LoseINNV / S&P -132.35% / 42.23% |
| 2021-Q40/3 |
LoseINNV / S&P -24.36% / 11.03% |
LoseINNV / S&P 11.40% / 15.00% |
LoseINNV / S&P -121.05% / 96.40% |
| 2021-Q30/3 |
LoseINNV / S&P -68.98% / 0.58% |
LoseINNV / S&P INNV unavailable / 10.77% |
LoseINNV / S&P INNV unavailable / 69.42% |
| 2021-Q20/3 |
LoseINNV / S&P -17.37% / 8.55% |
LoseINNV / S&P INNV unavailable / 6.58% |
LoseINNV / S&P INNV unavailable / 51.81% |
| 2021-Q10/3 |
LoseINNV / S&P INNV unavailable / 6.17% |
LoseINNV / S&P INNV unavailable / -1.06% |
LoseINNV / S&P INNV unavailable / 7.39% |
| 2020-Q40/3 |
LoseINNV / S&P INNV unavailable / 12.15% |
LoseINNV / S&P INNV unavailable / -3.72% |
LoseINNV / S&P INNV unavailable / -33.42% |
| 2020-Q30/3 |
LoseINNV / S&P INNV unavailable / 8.93% |
LoseINNV / S&P INNV unavailable / -2.04% |
LoseINNV / S&P INNV unavailable / -27.10% |
| 2020-Q20/3 |
LoseINNV / S&P INNV unavailable / 20.54% |
LoseINNV / S&P INNV unavailable / -0.46% |
LoseINNV / S&P INNV unavailable / -27.11% |
| 2020-Q10/3 |
LoseINNV / S&P INNV unavailable / -19.60% |
LoseINNV / S&P INNV unavailable / 3.47% |
LoseINNV / S&P INNV unavailable / -14.75% |
| 2019-Q40/3 |
LoseINNV / S&P INNV unavailable / 9.07% |
LoseINNV / S&P INNV unavailable / 5.36% |
LoseINNV / S&P INNV unavailable / 2.99% |
| 2019-Q30/3 |
LoseINNV / S&P INNV unavailable / 1.70% |
LoseINNV / S&P INNV unavailable / 5.02% |
LoseINNV / S&P INNV unavailable / 0.21% |
| 2019-Q20/3 |
LoseINNV / S&P INNV unavailable / 4.30% |
LoseINNV / S&P INNV unavailable / 6.64% |
LoseINNV / S&P INNV unavailable / 8.65% |
| 2019-Q10/3 |
LoseINNV / S&P INNV unavailable / 13.65% |
LoseINNV / S&P INNV unavailable / 8.12% |
LoseINNV / S&P INNV unavailable / 14.29% |
| 2018-Q40/3 |
LoseINNV / S&P INNV unavailable / -13.52% |
LoseINNV / S&P INNV unavailable / 9.05% |
LoseINNV / S&P INNV unavailable / 18.23% |
| 2018-Q30/3 |
LoseINNV / S&P INNV unavailable / 7.71% |
LoseINNV / S&P INNV unavailable / 10.21% |
LoseINNV / S&P INNV unavailable / 19.06% |
| 2018-Q20/3 |
LoseINNV / S&P INNV unavailable / 3.43% |
LoseINNV / S&P INNV unavailable / 9.03% |
LoseINNV / S&P INNV unavailable / 14.46% |
| 2018-Q10/3 |
LoseINNV / S&P INNV unavailable / -0.76% |
LoseINNV / S&P INNV unavailable / 7.68% |
LoseINNV / S&P INNV unavailable / 12.46% |
| 2017-Q40/3 |
LoseINNV / S&P INNV unavailable / 6.64% |
LoseINNV / S&P INNV unavailable / 7.03% |
LoseINNV / S&P INNV unavailable / 13.82% |
| 2017-Q30/3 |
LoseINNV / S&P INNV unavailable / 4.48% |
LoseINNV / S&P INNV unavailable / 5.68% |
LoseINNV / S&P INNV unavailable / 17.57% |
| 2017-Q20/3 |
LoseINNV / S&P INNV unavailable / 3.09% |
LoseINNV / S&P INNV unavailable / 4.83% |
LoseINNV / S&P INNV unavailable / 17.74% |
| 2017-Q10/3 |
LoseINNV / S&P INNV unavailable / 6.07% |
LoseINNV / S&P INNV unavailable / 3.67% |
LoseINNV / S&P INNV unavailable / 13.32% |
| 2016-Q40/3 |
LoseINNV / S&P INNV unavailable / 3.82% |
LoseINNV / S&P INNV unavailable / 2.09% |
LoseINNV / S&P INNV unavailable / 7.05% |
| 2016-Q30/3 |
LoseINNV / S&P INNV unavailable / 3.85% |
LoseINNV / S&P INNV unavailable / 0.20% |
LoseINNV / S&P INNV unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | INNV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 187.99% | 20.78% |
| Annualized return | 187.99% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | INNV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -25.62% | 83.14% |
| Annualized return | -5.75% | 12.86% |
10Y · 2021-03-04 to 2026-08-27
| Metric | INNV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -54.42% | 319.30% |
| Annualized return | -7.56% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |